Facebook X (Twitter) Instagram
    Facebook Instagram Threads
    Global BiodefenseGlobal Biodefense
    Subscribe
    • Featured News
    • Funding
    • Directory
    • Jobs
    • Events
    Global BiodefenseGlobal Biodefense
    CBRNE

    RFI – CounterACT Investigator-Industry Partnerships

    By Global Biodefense StaffFebruary 4, 2016
    NIH CounterACT Chemical Countermeasure Program
    Share
    Facebook LinkedIn Reddit Email

    The mission of the NIH Countermeasures Against Chemical Threats (CounterACT) program is to develop new and improved therapeutics to treat or prevent injuries resulting from exposure to chemical threats.

    The NIH is seeking to establish new partnerships between funded researchers and industrial entities to work towards development of such medical countermeasure products and the sustainability of the overall research enterprise.

    Many NIH CounterACT projects are developing candidate therapeutics and are now poised for more advanced development activities, including pre-Investigational New Drug (pre-IND)-enabling and clinical studies that could be supported by other federal agencies that fund advanced development.

    The majority of projects supported by NIH are in academic labs that often do not possess the resources and expertise for these types of advanced studies. To address this need, it is critical that the NIH facilitate partnerships between academic laboratories and pharmaceutical or biotechnology companies that typically have more experience in drug development and regulatory approval.

    The NIH is specifically seeking input from industry stakeholders on potential interest in attending a meeting with CounterACT investigators. They further request inputs on which characteristics of a project would influence interest in a countermeasure under development; and market influences beyond biodefense important to the development decision-making process.

    The CounterACT meeting would also include presentations from federal government officials on the various funding programs available to support the advanced development of medical products within this mission.

    Further details are available via Notice Number: NOT-NS-16-005. Responses to this RFI must be submitted no later than February 29, 2016.

    NIH
    Share. Facebook LinkedIn Reddit Email
    Previous ArticleThe Global Mission of the DoD Chemical-Biological Program
    Next Article Sandia Recognized for Decontamination Technology Transfer

    Related Stories

    Jurata Thin Film and CastleVax Awarded Grant to Advance Thermostabilized COVID-19 Booster

    September 20, 2023

    SOREX Brings Top CBRNE Units to Dugway Proving Ground

    September 20, 2023

    Biomarkers for Detection of Exposure to Nitrogen Mustards

    September 20, 2023

    Mount Sinai to Lead Development of Pan-Coronavirus Vaccine Under New Federal Grant

    September 17, 2023
    News Scan

    Biodefense Headlines – 19 September 2023

    News Scan September 19, 2023

    News highlights on health security threats and countermeasures curated by Global Biodefense This week’s selections include a global survey of gain-of-function research; funding of an mRNA mpox vaccine; Nipah virus outbreak in India; field detection of threat agents with acoustic…

    Upcoming Events

    Oct 3
    Virtual Event Virtual Event
    October 3 - October 5

    OneLab Summit 2023

    Oct 3
    Virtual Event Virtual Event
    12:00 pm - 2:00 pm EDT

    Public-Private Partnerships to Distribute, Dispense, and Administer Medical Countermeasures

    Oct 4
    Virtual Event Virtual Event
    10:00 am - 2:00 pm EDT

    Tunneling Nanotubes and Intracellular Protrusions Workshop

    Oct 12
    Virtual Event Virtual Event
    12:00 pm - 2:00 pm EDT

    Public-Private Partnerships for Acceptance and Uptake of Medical Countermeasures

    View Calendar

    Subscribe to Global Biodefense

    Get the latest news on pathogens and preparedness

    © 2023 Stemar Media Group LLC
    • About
    • Contact
    • Privacy
    • Subscribe

    Type above and press Enter to search. Press Esc to cancel.

    We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are okay with it.OkPrivacy policy